TRxADE HEALTH, Inc. (MEDS)

TRxADE HEALTH Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net Income	4.03	-17.84	-3.47	-5.32	-2.54	-0.28
Depreciation & Amortization	1.01	1.05	0.19	0.14	0.1	0.09
Share-Based Compensation	4.68	0.29	0.33	0.37	1.81	0.18
Other Operating Activities	-21.05	14.43	1.38	2.24	-1.59	0.16
Operating Cash Flow	-11.33	-2.07	-1.56	-2.57	-2.21	0.14
Operating Cash Flow Growth	-	-	-	-	-	-48.14%
Capital Expenditures	0.09	0	0	-0.02	-0.04	-0.08
Acquisitions	-0.34	-0.34	0	0	0	0
Change in Investments	-2.5	0	0	0	0	-0.25
Other Investing Activities	29.58	0.07	-0.43	-	-	-
Investing Cash Flow	26.82	-0.28	-0.43	-0.02	-0.04	-0.33
Dividends Paid	-12.67	0	0	0	0	0
Share Issuance / Repurchase	0.03	0	0.13	0.02	5.3	2.46
Debt Issued / Paid	2.12	2.95	0.83	-0.23	0	-0.26
Other Financing Activities	-2.65	-1.54	-0.99	-	-	-
Financing Cash Flow	-13.17	1.41	-0.04	-0.21	5.3	2.19
Net Cash Flow	2.32	-0.94	-2.03	-2.8	3.05	2
Free Cash Flow	-11.24	-2.07	-1.56	-2.59	-2.25	0.06
Free Cash Flow Growth	-	-	-	-	-	-76.96%
Free Cash Flow Margin	-168.80%	-25.07%	-15.26%	-26.18%	-13.15%	0.80%
Free Cash Flow Per Share	-10.85	-2.71	-2.77	-4.77	-4.38	0.15

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).